Solid prices $125M IPO, discloses partial clinical hold

Solid Biosciences Inc. (NASDAQ:SLDB) raised $125 million after market hours Thursday through the sale of 7.8 million shares at $16 in a downsized IPO underwritten by J.P. Morgan, Goldman Sachs, Leerink,

Read the full 312 word article

User Sign In